ARMISTICE CAPITAL, LLC Neurocrine Biosciences, Inc. Transaction History

ARMISTICE CAPITAL, LLC portfolio value:

$140.62M
portfolio value

ARMISTICE CAPITAL, LLC quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 11.55M $106.21 1.32M
Q2 2022 share Increase +103.69% 674K shares 68.12M $97.48 1.32M
Q1 2022 share Increase 0.00% 650K shares 60.93M $93.75 650K